Pulse.

a daily field guide to health research that matters

◆ Console

‹ Sat · 7 Nov 2026
Near-term implementable finding

Prediction of overall survival in acute myeloid leukemia using supervised machine learning.

Machine learning models using patient data predict outcomes better than current genetic guidelines for untreated acute leukemia, suggesting clinical factors matter most.

Machine learning models integrating clinical, cytogenetic, and molecular features were trained and validated on 785 AML patients from multicenter Danish real-world practice, demonstrating C-index >0.75 for non-intensively treated patients versus approximately 0.57 for ELN2024. Clinical variables contributed most to prognostic accuracy, and adding genetic features did not consistently improve performance, suggesting guideline-based genomic risk stratification is insufficient for non-intensive AML prognosis.

What the study was

Study design
retrospective_ml_cohort
Category
hematologic_malignancies
Maturity
Validated
Journal
ESMO Real World Data and Digital Oncology

Why it surfaced

Multicenter Danish ML model outperforms ELN2024 in non-intensive AML; demonstrates clinical variables matter most; practical for personalized risk stratification in treatment-ineligible or elderly patients.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.